FDA Drug recall D-0302-2015
BELVIQ¿ (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle, Rx only, Manufactured by: Arena Pharmaceuticals, GmbH, Zofingen, Switzerland, Dis…
- FDA Drug
- Class III
- terminated
- Published 2014-12-24
On 2014-12-24 the FDA classified a Class III recall of BELVIQ¿ (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle, Rx only, Manufactured by: Arena Pharmaceuticals, GmbH, Zofingen, Switzerland, Dis… by Eisai, citing labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0302-2015 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2014-12-05 |
| Published | 2014-12-24 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Eisai |
| Distribution | US |
Product
BELVIQ¿ (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle, Rx only, Manufactured by: Arena Pharmaceuticals, GmbH, Zofingen, Switzerland, Distributed by: Elsai Inc., Woodcliff, NJ 07677 NDC 62856-52960.
Reason
Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date.
Identifiers
| code_info | Lot #13297008, Exp. 11/15;13307008, Exp. 11/15;13367008, Exp.12/15. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0302-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.